CXHL2200893 | 莫非赛定利托那韦片 | morphothiadine mesylate;ritonavir | Tablet | Chemical Drugs(1) | New Drug Application | 2022-11-12 | | Sunshine Lake Pharma Co Ltd | | | view |
JYHB1400866 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2014-07-18 | AbbVie Ltd, | Abbvie Ltd | Certificate Issued | 2015-01-27 | view |
JTH2200240 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Disposable Import Drug Application | 2022-12-21 | | | | | view |
JYHB1601599 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2016-12-06 | AbbVie Ltd, | Abbvie Ltd | Certificate Issued | 2017-07-18 | view |
JYHB1001167 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2010-12-31 | Abbott Laboratories Limited | Abbott Laboratories Ltd | Certificate Issued | 2011-08-29 | view |
CYHS2200484 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs(4) | Generic Drug | 2022-03-24 | | Shanghai DESANO Biopharmaceutical Co Ltd | | | view |
JYHB1500737 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2015-06-02 | AbbVie Ltd, | Abbvie Ltd | Certificate Issued | 2016-07-18 | view |
JYHS2300030 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2023-02-22 | | | | | view |
JYHB2000638 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2020-05-27 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Filed | 2020-06-09 | view |
JYHZ1700275 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | License Renew | 2017-08-21 | AbbVie Ltd. | Abbvie Ltd | Certificate Issued | 2018-03-19 | view |
JYHB1000056 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2010-02-03 | Abbott Laboratories Limited | Abbott Laboratories Ltd | Certificate Issued | 2010-06-24 | view |
JYHB1900177 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2019-02-12 | AbbVie Deutschland GmbH & Co. KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2019-09-23 | view |
JYHB1901349 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2019-11-13 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2020-01-20 | view |
JYHB1601600 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2016-12-06 | AbbVie Ltd. | Abbvie Ltd | Certificate Issued | 2017-05-04 | view |
JYHB2001606 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2020-08-28 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2020-11-24 | view |
JYHB1001168 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2010-12-31 | Abbott Laboratories Limited | Abbott Laboratories Ltd | Certificate Issued | 2011-08-29 | view |
JYHB1401281 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2014-09-17 | AbbVie Ltd, | Abbvie Ltd | Certificate Issued | 2015-01-27 | view |
JYHB2000637 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2020-05-27 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Filed | 2020-06-09 | view |
JYHB0901041 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2009-12-04 | Abbott Laboratories Limited | Abbott Laboratories Ltd | Certificate Issued | 2010-05-18 | view |
JYHZ2200202 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | License Renew | 2022-07-18 | | | | | view |